ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P10
Near historical low
vs 2Y Ago
-0.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -171.36% |
| Q3 2025 | -54.52% |
| Q2 2025 | 306.96% |
| Q1 2025 | -296.64% |
| Q4 2024 | -36.80% |
| Q3 2024 | 152.57% |
| Q2 2024 | -13.98% |
| Q1 2024 | -65.95% |
| Q4 2023 | 244.71% |
| Q3 2023 | -819.49% |
| Q2 2023 | 145.73% |
| Q1 2023 | 24.82% |
| Q4 2022 | -3181.16% |
| Q3 2022 | 94.46% |
| Q2 2022 | 82.80% |
| Q1 2022 | -230.13% |
| Q4 2021 | -35.50% |
| Q3 2021 | 32.74% |
| Q2 2021 | 58.56% |
| Q1 2021 | -107.63% |
| Q4 2020 | -20.29% |
| Q3 2020 | 38.43% |
| Q2 2020 | 20.27% |
| Q1 2020 | -66.93% |
| Q4 2019 | -58.02% |
| Q3 2019 | 50.72% |
| Q2 2019 | 40.89% |
| Q1 2019 | -63.93% |
| Q4 2018 | 8.42% |
| Q3 2018 | -5.62% |
| Q2 2018 | 10.27% |
| Q1 2018 | -52.78% |
| Q4 2017 | 48.85% |
| Q3 2017 | 1.19% |
| Q2 2017 | 16.84% |
| Q1 2017 | -12.15% |
| Q4 2016 | -27.56% |
| Q3 2016 | 23.87% |
| Q2 2016 | -57.72% |
| Q1 2016 | -18.29% |